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Background: The cosmopolitan microcrustacean Daphnia pulex provides a model system for both human health
research and monitoring ecosystem integrity. It is the first crustacean to have its complete genome sequenced, an
unprecedented ca. 36% of which has no known homologs with any other species. Moreover, D. pulex is ideally
suited for experimental manipulation because of its short reproductive cycle, large numbers of offspring,
synchronization of oocyte maturation, and other life history characteristics. However, existing gene manipulation
techniques are insufficient to accurately define gene functions. Although our previous investigations developed an
RNA interference (RNAi) system in D. pulex, the possible time period of functional analysis was limited because the
effectiveness of RNAi is transient. Thus, in this study, we developed a genome editing system for D. pulex by first
microinjecting transcription activator-like effector nuclease (TALEN) mRNAs into early embryos and then evaluating
TALEN activity and mutation phenotypes.
Results: We assembled a TALEN construct specific to the Distal-less gene (Dll), which is a homeobox transcription
factor essential for distal limb development in invertebrates and vertebrates, and evaluated its activity in vitro by
single-strand annealing assay. Then, we injected TALEN mRNAs into eggs within 1 hour post-ovulation. Injected
embryos presented with defects in the second antenna and altered appendage development, and indel mutations
were detected in Dll loci, indicating that this technique successfully knocked out the target gene.
Conclusions: We succeeded, for the first time in D. pulex, in targeted mutagenesis by use of Platinum TALENs. This
genome editing technique makes it possible to conduct reverse genetic analysis in D. pulex, making this species an
even more appropriate model organism for environmental, evolutionary, and developmental genomics.
Keywords: Daphnia pulex, Distal-less, Platinum TALEN, Gene disruption, Knock-out, Targeted mutagenesis, Gene
manipulation, Genome editingBackground
Environmental cues constantly influence gene expression;
hence interactions among them are indispensable for
animal adaptations against changing environments. The
water flea Daphnia pulex shows a striking ability to con-
tend with environmental changes, resulting in various* Correspondence: taisen@nibb.ac.jp
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unless otherwise stated.adaptive phenotypes involving traits such as body size,
longevity, behavior, and morphology [1]. It is well known
that daphnids occupy a key position as the intermediate
link between primary productivity and top predators in the
aquatic food chain, and they also serve as an environmental
indicator organism because of their high sensitivity to water
quality [2]. These characteristics, in addition to their short
life cycle, large brood sizes, and synchronization of oocyte
maturation, make them valuable for environmental, evolu-
tionary, and developmental genomics studies. Further-
more, the D. pulex genome has been sequenced [3], which
facilitates the identification of candidate genes involved intd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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scriptomics, proteomics, and metabolomics also showed
profiles of a large number of putative factors involved in
their unique life history characteristics (cf. [4,5]). The D.
pulex genome possesses as many as about 31,000 genes;
this large suite of genes may provide the arsenal respon-
sible for the organism’s responsiveness to environmental
challenges [3]. So far, however, there are no effective
methods for manipulating genes, and only transient ana-
lysis of gene function by the RNA interference (RNAi)
method [6] is available. The RNAi system in D. pulex
suffers from several weaknesses, including incomplete si-
lencing, transient effects, and limited analyzable stages.
Because of these situations, even in the post-genomic era,
the establishment of a gene manipulation technique has
been eagerly anticipated to address the characterization of
gene function in D. pulex.
There are three main types of artificial sequence-specific
nucleases based on the source mechanism of DNA binding
that guides nuclease activity to a genomic target: zinc-
finger nucleases (ZFNs), transcription activator-like effector
nucleases (TALENs), and clustered regularly interspaced
short palindromic repeats (CRISPR) [7]. In this study, we
chose TALEN to edit the D. pulex genome, although each
method has both advantages and disadvantages in terms of
cost, sequence-specificity, off-target effects, and so on [8,9].
The transcription activator-like effectors (TALEs) were first
discovered in the plant pathogen Xanthomonas sp., and are
composed of a conserved central domain for site-specific
DNA binding [10,11]. The DNA-binding domain consists
of varying numbers of tandem repeats of a 34-amino acid
monomer, which specifies the DNA-binding sequence by
its 12th and 13th amino acids, called repeat-variable di-
residues (RVDs). RVDs specifically recognize a single nu-
cleotide with the following codes: NG=T, HD=C, NI =A,
NN=G or A [10,12,13]. Sakuma et al. [14] demonstrated
that TALENs with periodically-patterned repeat variants
harboring non-RVD variations, called Platinum TALENs,
showed higher activities than TALENs without non-RVD
variations (so-called Golden TALENs). TALENs are artifi-
cially generated by fusing TAL effector DNA-binding
domains to a Fok I nuclease domain, and successfully har-
nessed to custom-designed sequence-specific nucleases
[15,16]. TALENs induce DNA double-strand breaks (DSBs)
that can be repaired by the error-prone non-homologous end
joining (NHEJ) system to cause insertion and/or deletion
mutations at targeted genomic loci.
TALEN-mediated gene targeting has been applied in a
great number of vertebrates and invertebrates [7,9,17]. In
arthropods, it has been reported in insect species including
flies [18], mosquitos [19,20], crickets [21], and silkworms
[22]. Very recently, mutagenesis of an eye development
gene was achieved in one congener Daphnia magna using
the CRISPR/Cas system [23]. However, the conditionsdeveloped in D. magna are not directly applicable to D.
pulex, possibly because of the difference in egg size and
contents, and developmental duration, as described in our
previous study [6].
Distal-less (Dll) and its homologs, Dlx genes, which
function as homeodomain transcription factors, play one
of the major roles in distal limb development throughout
the animal kingdom [24]. Reduction of Dll activity caused
defects of distal appendage segments in arthropods, result-
ing in the production of an easily recognizable phenotype
(cf. [25,26]). In addition, the results of Dll RNAi in D.
pulex [6] provide possible comparative data regarding
phenotype, which is why this endogenous developmental
gene was selected as a target for proof-of-principle TALEN
in D. pulex.
The goal of this study was to develop a targeted gene
disruption system by TALEN-mediated artificial DSBs in D.
pulex. A TALEN target site was designed and assembled,
and then TALEN mRNAs were microinjected into embryos
to successfully induce insertion and/or deletion mutations.
Results and discussion
Construction and evaluation of Dll TALENs
We first cloned and sequenced the partial sequence of the
Dll gene in D. pulex, and then designed two pairs of
TALENs, Dll_A and Dll_B, targeted to the first exon to
induce a nonsense mutant protein (Figure 1). After con-
structing the TALENs by the Platinum Gate TALEN Kit, the
activities of TALENs were evaluated by human cell-based
single-strand annealing (SSA) assay [27] (Figure 2). Both
Dll_A and Dll_B TALENs showed higher scores than the
positive control ZFN [28], suggesting that both TALENs
have DSB-inducing activities. We have evaluated the TALEN
activities using human cells for various animal applications
including sea urchin [29] and fruit fly [27,30], suggesting that
the activity score measured in human cells is, in principle, a
good indication of the level of inducing DSBs in a wide
range of animals. SSA assay can directly be performed with
the constructed TALEN plasmids in human cells, so that we
can easily know the quality of the constructed TALENs
before making mRNAs and injecting them into the animals.
We thus think the validation process with human cell-
based SSA assay is beneficial to apply TALENs in animals
including D. pulex.
Detection of mutations and their sequences
Two pairs of Dll TALEN mRNAs were microinjected into
eggs just after ovulation, and the genome modification effi-
ciencies in vivo were evaluated by a T7 endonuclease I
(T7EI) assay. We found that a signal intensity of undigested
band in the TALEN-injected embryos was weaker than that
in uninjected embryos (Figure 3A). Furthermore, multiple
digested bands were detected in Dll_B-injected embryos,
whereas only a slightly separated band was detected in
Figure 1 The first exon nucleotide sequence of the D. pulex Dll gene. Two pairs of TALENs, Dll_A and Dll_B, were designed in the first exon
(highlighted in gray). The spacer regions of Dll_A and Dll_B each contain 15 bp nucleotides. Underline indicates ATG start codon.
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exhibits higher genome modification efficiencies rather
than Dll_A.
To investigate the successful genome modifications of the
F0 founder line, the genomic region surrounding the
TALEN target was amplified and subcloned. Sequencing
analysis revealed that TALENs predominantly induce small
indel mutations ranging in size from 6-13 bp (Figure 3B),Figure 2 Activity evaluation of Dll_A and Dll_B TALENs by SSA
assay. TALEN plasmids and the corresponding reporter plasmid,
TALEN plasmids and unrelated reporter plasmid, or the reporter
plasmid without TALEN plasmids were transfected into HEK293T
cells. After the luciferase assay, fold activation scores against the
positive control ZFN (pSTL-ZFA36 with the corresponding reporter)
[28] were calculated. Data are expressed as means ± SEM (n = 3).which is similar to results obtained in other arthropods
[18-22]. In Dll_A-injected F0 founders, only two types of
mutations, 6- and 9-nucleotide deletions, were detected.
These mutations did not cause a frame shift and growth
defect (see next section), suggesting that the gene function
was not compromised. On the other hand, seven types of
mutations were detected in Dll_B-injected F0 founders, five
of which induced a frame shift leading to the appearance of
a stop codon in the first exon. These mutations are
predicted to result in a very short protein (83 amino acids)
without a homeodomain, which is a functional DNA-
binding domain and highly conserved among other arthro-
pods. The variations of mutation patterns in Dll_B-injected
F0 founders were higher than those in Dll_A-injected F0
founders, as expected from the T7EI assay. Based on these
results, we conclude that the T7EI assay is a quick and easy
method for estimating TALEN in vivo activity in F0
embryos of D. pulex.
To investigate whether these mutations were heritable,
we then cloned and sequenced the target genomic
region from F2 embryos. DNA sequencing revealed that
inherited modifications existed in the two and one F2
lines injected with Dll_A and B, respectively (Figure 3C).
Progeny from the same F0 founder had the same mutation
genotype, indicating that the F0 founder carried a single
germline mutation, not a mosaic germline mutation. Be-
cause cleavage proceeds without cytokinesis during injec-
tion period [31] and TALEN mRNAs can easily diffuse
throughout the egg, it is considered that this method is
able to induce mutation at very early developmental stages
and easily establish mutant lines having a single germline
Figure 3 Detection of TALEN-induced mutations and their sequences. (A) Mutations in Dll were detected by T7EI assay. Arrowheads indicate
the cleavage products generated in T7EI assay of F0 founders. (B) Sequence analysis of Dll mutant alleles in F0 founders induced by TALENs. The wild
type (WT) sequence is shown at the top with the TALEN-binding sites (highlighted in gray). The number of nucleotides deleted (-) and inserted (+) is
indicated in parentheses. (C) Sequence analysis of Dll mutant alleles in F2 embryos. Binding sites and insertions/deletions indicated as in (B).
Hiruta et al. BMC Biotechnology 2014, 14:95 Page 4 of 8
http://www.biomedcentral.com/1472-6750/14/95mutation, without a need for complicated screening. In
other words, mutation analysis can be carried out in a
mere generation.
Phenotype of Dll TALEN in D. pulex
Results from TALEN experiments are summarized in
Table 1. Compared to uninjected embryos, the low viabil-
ity of the embryos injected with Dll TALEN mRNAs may
be partly attributed to damage due to microinjection and/
or toxicity of TALEN mRNAs, as well as the embryonic
lethality of Dll knock-out mutants. The difference of via-
bility and/or morphological phenotype among embryos
injected with Dll_A or Dll_B might depend on their gen-
etic phenotype, such as non-mosaic/mosaic, monoallelic/
biallelic, and non-frame shift/frame shift mutations. When
a half concentration of Dll_B (250 ng/μl) was injected,
viability of injected embryos increased by 7.5% and two in-
dividuals did not have any prominent altered phenotypes,
suggesting dose dependency of the TALENs on viability
and phenotypes.
Morphologically, the Dll_A injected embryos did not
show any prominent altered phenotypes, and bothTable 1 Summary of TALEN results




Uninjected - 130homozygous and heterozygous non-frame shift mutations
were detected in Dll loci. Hence, we assessed the pheno-
type of Dll_B-injected F0 founders hereafter. Similar to the
RNAi knockdown phenotype of Dll [6], Dll_B-injected F0
founders displayed various degrees of defects in second
antennae, appendages, ocellus, abdominal claw, and
abdominal setae, all tissues in which Dll is normally
expressed (Figure 4 and Additional file 1: Figure S1). In
the second antennae, the degree of the segment truncation
was variably detected, ranging from severe (peduncle
alone, lacking dorsal and ventral rami) to mild (peduncle
and deficient rami). The first to fifth thoracic appendages,
including each exopodite, were shortened. Moreover, a
loss of the ocellus and abdominal setae, and minimized
abdominal claw, were observed in Dll_B-injected embryos.
We found that the mutants with severe defects in the sec-
ond antenna and appendage development have biallelic
mutations, failed to molt, and died before becoming
adults. The lethality of Dll knock-out mutants was in
accordance with previous studies on insects [25,32]. This
easy and efficient induction of biallelic mutations by





Figure 4 (See legend on next page.)
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Figure 4 Major Dll_B TALEN phenotypes. The left and right columns show representative phenotypes of uninjected controls and individuals
injected with Dll_B mRNAs, respectively. (A, B) Lateral view of first instar juvenile. (C, D) Lateral view of the second antennae. (E, F) Second thoracic
limb (T2). Dr, dorsal ramus; Ep, epipodite; En, endopodite; Ex, exopodite; Gn, gnathobase; Pe, peduncle; Vr, ventral ramus. Scale bars =200 μm in A, B;
100 μm in C, D and E, F.
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suited for conducting crossing experiments. In cases where
monoallelic mutants are obtained, it is possible that the
mutant line could be maintained and embryos reinjected
with TALEN mRNAs to induce biallelic mutations.
Our results demonstrated that TALENs worked in D.
pulex to induce heritable mutations into the endogenous
genes. Moreover, TALENs can be used to induce more com-
plicated mutagenesis other than micro-deletions or inser-
tions. For example, Ma et al. [22] showed that simultaneous
expression of two pairs of TALENs generates heritable large
chromosomal deletions. Furthermore, Bedell et al. [33] and
Zu et al. [34] demonstrated that co-injection of TALEN
mRNAs and single-stranded oligodeoxyribonucleotides or
donor vectors induced knock-in of small and large DNA
fragments, respectively, into target loci via homologous
recombination. All these technique based on TALENs will
enable us to accurately define gene functions in D. pulex
in future investigations.
Conclusions
We developed a TALEN-mediated gene targeting model
in D. pulex. Targeted mutagenesis can be attained in early
embryos by injecting the right and left TALEN mRNAs
into eggs within 1 hour post-ovulation. The genome edit-
ing by Platinum TALENs presented here, together with
the full-genome sequence and other developed molecular
tools, may significantly promote the genetic tractability of
D. pulex as an important model for environmental, evolu-
tionary, and developmental genomics.
Methods
Daphnia strain and culture conditions
The D. pulex strain [West Trenton (WTN6), collected in
May 2006 by Sarah Schaak] was obtained from the Center
for Genomics and Bioinformatics (Indiana University,
USA). The strains were maintained in dechlorinated tap
water, which was aerated and filtered through activated
carbon for 2 weeks, at 18°C under artificial light condi-
tions of 14 h light and 10 h dark to maintain reproduction.
A 0.01-ml suspension of 109 cells/ml Chlorella vulgaris
was added every day to each culture (20-25 individuals/L).
For rearing embryos, M4 culture medium (M4) was prepared
using MilliQ water [35].
Cloning of Distal-less
Total RNA was extracted using an ISOGEN kit (NIPPON
GENE, Tokyo, Japan), and converted to cDNA usingSuperscript III and random primers (Life Technologies,
Carlsbad, CA, USA) according to the manufacturer’s proto-
col. The Dll fragment was PCR amplified from the cDNA
using a set of primers designed from the Dll sequence
retrieved from wFleaBase http://wfleabase.org/ (Additional
file 2: Table S1). Subsequently, the cDNA fragments were
cloned into the pGEM-T Easy vector (Promega, Madison,
WI, USA) according to the manufacturer’s instructions. Plas-
mids were sequenced using Sanger techniques that included
the Big Dye terminator Ver. 3.1 (Life Technologies) on an
ABI 3100 Avant or ABI 3130 Genetic Analyser DNA
sequencer (Applied Biosystems Japan Ltd, Tokyo, Japan).
TALEN target site design and assembly
The first exon sequences of Dll gene were scanned for po-
tential TALEN target sites, which were identified using
the TALEN Targeter program at https://tale-nt.cac.cornell.
edu/node/add/talen. The following parameters were used:
1) spacer length: 12-16; 2) repeat array length of 15-20; 3)
G substitute: NN; 4) Filter Options: Show all TALEN pairs
(include redundant TALENs); 5) Streubel et al. guidelines:
On. The Platinum Gate TALEN construction system de-
scribed in Sakuma et al. [14] was used to assemble two
pairs of TALENs, Dll_ A and Dll_ B (Figure 1), using the
Platinum Gate TALEN Kit (Addgene, cat#1000000043).
Assembled RVD repeats were as follows: HD NN NI HD
NN NI HD NN HD HD HD NI NI NG NG HD for the
left Dll_A TALEN, NN NG NG NN NG NG NN HD NG
NN NN NG HD NN HD NI NI for the right Dll_A
TALEN, HD NI NG HD HD NN NN NI HD NI NN HD
NI NN HD NI NN for the left Dll_B TALEN, and NN HD
NN NN HD NN NN HD HD NN HD NG NN HD NI
NN HD for the right Dll_B TALEN. ptCMV-153/47-VR
vectors (Addgene, included in the Platinum Gate TALEN
Kit) were used as destination vectors.
Single-strand annealing (SSA) assay in human cells
Construction of the reporter plasmids and the SSA assay
was performed as previously reported [27]. Briefly, the
oligonucleotides listed in Additional file 3: Table S2 were
annealed and inserted into pGL4-SSA vector (Addgene,
Plasmid 42962) to construct the reporter plasmids. The
TALEN plasmids and/or reporter plasmids were trans-
fected into HEK293T cells using Lipofectamine LTX
(Life Technologies) according to the manufacturer’s
instruction. At 24 hours post-transfection, a luciferase
assay was performed using Dual-Glo Luciferase Assay
System (Promega) and intensity of luminescence was
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Technologies, Bad Wildbad, Germany).
Injection of TALEN mRNAs into embryos
TALEN plasmid templates were linearized with Sma I
(TaKaRa Bio, Shiga, Japan) and then transcribed in vitro
using the mMESSAGE mMACHINE T7 Ultra kit (Ambion,
Austin, TX, USA) according to the manufacturer’s protocol.
The resultant mRNAs were purified using a NucAway Spin
Columns (Ambion) and extracted with water-saturated
phenol/chloroform, and finally resuspended in RNase-free
water. Equal amounts of the right and left TALEN
mRNAs were mixed to a final concentration of 500 and
250 ng/μl for microinjection and stored at –80°C until
use. TALEN mRNAs were injected into the embryos as
described previously [6].
T7 endonuclease I (T7EI) assay
T7EI is a mismatch-resolving enzyme that can recognize
heteroduplex DNAs and cleave DNA at single base pair mis-
matches. Thus TALEN-induced indel mutations can be de-
tected. A pool of thirteen embryos collected at 48 h
following injection with Dll_ A or Dll_B was used. Genomic
DNA was isolated from TALEN-injected and uninjected em-
bryos using DNeasy Blood and Tissue kit (Qiagen, Hilden,
Germany). Additional file 2: Table S1 shows primers used to
amplify the region containing the Dll target site from gen-
omic DNA for T7EI assay and mutation analysis. PCR was
performed using TaKaRa Ex Taq (TaKaRa Bio). Amplifica-
tion conditions were: 98°C for 10 s, 56°C for 30 s, 72°C for
20 s, 45 cycles. T7 endonuclease I (New England Biolabs,
Beverly, MA, USA) was added to PCR fragments and incu-
bated at 37°C for 60 min. The samples were electrophoresed
using 2% agarose gels.
Mutation analysis
To confirm the presence of TALEN-mediated mutations,
genomic DNA of each individual was isolated separately
from twelve F0 embryos and nine F2 embryos injected
with Dll _A or Dll _B as described above. The target
genomic region was amplified with TaKaRa Ex Taq
(TaKaRa Bio). Amplification conditions were: 98°C for
1 min; 35 cycles of 98°C for 10 s, 56°C for 30 s, 72°C for
20 s; 72°C for 1 min. The resulting fragments were sub-
cloned into the pGEM-T Easy vector (Promega) and
then sequenced as described above. For observation of
morphological changes, first instar animals were exam-
ined under a stereomicroscope (M165 FC; Leica Micro-
systems GmbH, Wetzlar, Germany), and then fixed in
ethanol and dissected with a pair of needles. The speci-
mens were mounted in glycerin, observed by Nomarski
differential interference contrast microscopy (Axioplan
2; Zeiss, Oberkochen, Germany), and recorded by digitalcamera (DP72; Olympus). The terminology used herein
for morphology follows the usage of Stachowitsch [36].
Additional files
Additional file 1: Figure S1. Phenotypes of Dll_B mRNAs injected
juveniles. The left and right columns show representative phenotypes of
uninjected controls and individuals injected with Dll_B mRNAs, respectively.
(A, B) First thoracic limb (T1). The exopodite and endopodite were
shortened by Dll_B TALEN mRNAs. (C, D) Third and fourth thoracic limbs
(T3/4), having the same morphology. The exopodite was shrunk in
Dll_B-injected juveniles. (E, F) Fifth thoracic limb (T5). The exopodite was
shortened by Dll_B mRNAs. (G, H) Lateral view of the rostrum and head;
an arrowhead indicates an ocellus. (I, J) Lateral view of abdomen; an arrow
and arrowhead show an abdominal claw and abdominal seta, respectively. Ep,
epipodite; En, endopodite; Ex, exopodite; Fc, filter comb. Scale bars =100 μm.
Additional file 2: Table S1. The list of primer sequences.
Additional file 3: Table S2. Oligonucleotides for construction of
reporter plasmids.
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